Jennifer Cheng
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Jennifer Cheng
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 40 | |
| Extinct | Household/Personal Care | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jennifer Cheng tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Verana Health, Inc.
 Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Packaged Software | Founder Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Founder Director/Board Member Corporate Officer/Principal | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Investor Relations Contact | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of San Francisco | College/University | Undergraduate Degree Undergraduate Degree | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| NEVRO CORP. | Medical Specialties | Corporate Officer/Principal Investor Relations Contact | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Solazyme, Inc. | Director/Board Member Corporate Officer/Principal | ||
Vantage Surgical Systems, Inc.
 Vantage Surgical Systems, Inc. Medical SpecialtiesHealth Technology Vantage Surgical Systems, Inc. develops medical imaging systems for minimally invasive procedures. The private company is based in Los Angeles, CA. The CEO of the company is Zohar Loshitzer. | Medical Specialties | Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Founder Founder | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree | |
| NKARTA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
PEAK Surgical, Inc.
 PEAK Surgical, Inc. Medical SpecialtiesHealth Technology PEAK Surgical is a medical device company that has developed the PEAK Surgery System, a new tissue dissection system based on a proprietary technology that represents an important advance in radiofrequency surgical technologies. The PEAK Surgery System consists of the PEAK PlasmaBlade, a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage, and the PULSAR Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlade. The PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States, and for use in general surgery in the European Union. It was launched in the United States in July 2008 and has been used by U.S. surgeons on many patients, including general, gynecologic, orthopedic and plastic and reconstructive surgeries | Medical Specialties | Founder Founder | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| San Francisco State University | College/University | Undergraduate Degree Undergraduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Corporate Officer/Principal | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Regno Unito | 3 |
| Francia | 3 |
| Svizzera | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 16 |
| Finance | 4 |
| Technology Services | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 229 |
| Corporate Officer/Principal | 111 |
| Independent Dir/Board Member | 86 |
| Chief Tech/Sci/R&D Officer | 49 |
| Undergraduate Degree | 40 |
Contatti più connessi
| Insiders | |
|---|---|
| Thomas Woiwode | 39 |
| Mark Blumenkranz | 36 |
| Ian Clark | 35 |
| Ann Mather | 33 |
| Clarence Machado | 31 |
| Mitchell Finer | 26 |
| Jim Scopa | 26 |
| Paul Cleveland | 18 |
| Rekha Hemrajani | 17 |
| John McLaughlin | 17 |
| Athena Countouriotis | 17 |
| Richard Spivey | 16 |
| Eric Carter | 15 |
| Linda Bain | 15 |
| Leone Patterson | 14 |
- Borsa valori
- Insiders
- Jennifer Cheng
- Connessioni Società
